PROM1 and renal cell carcinoma: Figure 3D shows that RCC-41-PDX-1/CD132+ and RCC-41-PDX-2/CD133− exhibit high cloning efficiency (60% and 40% respectively), while RCC-41-PDX-2/CD133+ display a lower cloning efficiency (5%).